Pain evaluation during gynaecological surveillance in women with Lynch syndrome

被引:0
作者
Jorien Helder-Woolderink
Geertruida de Bock
Harry Hollema
Magda van Oven
Marian Mourits
机构
[1] University Medical Center Groningen,
[2] Martini Hospital,undefined
来源
Familial Cancer | 2017年 / 16卷
关键词
Lynch syndrome; Endometrial sampling; Pain; Surveillance; Endometrial cancer; VAS score;
D O I
暂无
中图分类号
学科分类号
摘要
To evaluate perceived pain during repetitive annual endometrial sampling at gynaecologic surveillance in asymptomatic women with Lynch syndrome (LS) over time and in addition to symptomatic women without LS, undergoing single endometrial sampling. In this prospective study, 52 women with LS or first degree relatives who underwent repetitive annual gynaecological surveillance including endometrial sampling of which 33 were evaluated twice or more and 50 symptomatic women without LS who had single endometrial sampling, were included. Pain intensity was registered with VAS scores. Differences in pain intensities between subsequent visits (in LS) and between the two groups were evaluated. The use of painkillers before endometrial sampling was registered. If women with LS decided for preventive surgery, the reason was recorded. The LS group reported a median VAS score of 5.0 (range 0–10) at the first surveillance (n = 52) and at the second visit (n = 24). Women who repeatedly underwent endometrial sampling more often used painkillers for this procedure. During the study period 7/52 (13 %) women with LS choose for preventive surgery, another 4/52 (8 %) refused further endometrial sampling. Painful endometrial sampling was mentioned as main reason to quit screening. The median VAS score of the 50 symptomatic women was 5.0 (range 1–9). Endometrial sampling, irrespective of indication, is a painful procedure, with a median VAS score of 5.0. During subsequent procedures in women with LS, the median pain score does not aggravate although one in five women chose an alternative for endometrial sampling.
引用
收藏
页码:205 / 210
页数:5
相关论文
共 195 条
  • [1] Renkonen-Sinisalo L(2006)Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome Int J Cancer 120 821-824
  • [2] Butzow R(2005)Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment J Med Genet 42 491-496
  • [3] Leminen A(2007)Society of Gynecologic Oncologists Education Committee. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions Gynecol Oncol 107 159-162
  • [4] Lehtovirta P(2008)The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations Gastroenterology 135 419-428
  • [5] Mecklin JP(2010)Risks of Lynch syndrome cancers for MSH6 mutation carriers J Natl Cancer Inst 102 193-201
  • [6] Jarvinen HJ(2015)The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome Fam Cancer 14 51-60
  • [7] Quehenberger F(2009)Management of extra-colonic tumours in patients with Lynch syndrome Lancet Oncol 10 400-408
  • [8] Vasen HF(2010)Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma Int J Cancer 127 2678-2684
  • [9] Van Houwelingen HC(2015)The gynecological surveillance of women with Lynch syndrome in Sweden Gynecol Oncol 138 717-722
  • [10] Lancaster JM(2013)Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts Gut 62 812-823